These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
962 related articles for article (PubMed ID: 24768416)
1. The influence of axillary reverse mapping related factors on lymphedema in breast cancer patients. Ikeda K; Ogawa Y; Kajino C; Deguchi S; Kurihara S; Tashima T; Goto W; Nishiguchi Y; Tokunaga S; Fukushima H; Inoue T Eur J Surg Oncol; 2014 Jul; 40(7):818-23. PubMed ID: 24768416 [TBL] [Abstract][Full Text] [Related]
2. Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients. Helyer LK; Varnic M; Le LW; Leong W; McCready D Breast J; 2010; 16(1):48-54. PubMed ID: 19889169 [TBL] [Abstract][Full Text] [Related]
3. Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients? Tausch C; Baege A; Dietrich D; Vergin I; Heuer H; Heusler RH; Rageth C Eur J Surg Oncol; 2013 Aug; 39(8):880-6. PubMed ID: 23735162 [TBL] [Abstract][Full Text] [Related]
4. Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy. Boneti C; Korourian S; Bland K; Cox K; Adkins LL; Henry-Tillman RS; Klimberg VS J Am Coll Surg; 2008 May; 206(5):1038-42; discussion 1042-4. PubMed ID: 18471751 [TBL] [Abstract][Full Text] [Related]
5. Axillary reverse mapping: a prospective study in women with clinically node negative and node positive breast cancer. Connor C; McGinness M; Mammen J; Ranallo L; Lafaver S; Klemp J; Fan F; Mahnken J Ann Surg Oncol; 2013 Oct; 20(10):3303-7. PubMed ID: 23975287 [TBL] [Abstract][Full Text] [Related]
6. The incidence and risk factors for occurrence of arm lymphedema after treatment of breast cancer. Rebegea L; Firescu D; Dumitru M; Anghel R Chirurgia (Bucur); 2015; 110(1):33-7. PubMed ID: 25800313 [TBL] [Abstract][Full Text] [Related]
7. Does Axillary Reverse Mapping Prevent Lymphedema After Lymphadenectomy? Tummel E; Ochoa D; Korourian S; Betzold R; Adkins L; McCarthy M; Hung S; Kalkwarf K; Gallagher K; Lee JY; Klimberg VS Ann Surg; 2017 May; 265(5):987-992. PubMed ID: 27163955 [TBL] [Abstract][Full Text] [Related]
8. Axillary reverse mapping to prevent lymphedema after breast cancer surgery: defining the limits of the concept. Khan SA J Clin Oncol; 2009 Nov; 27(33):5494-6. PubMed ID: 19826108 [No Abstract] [Full Text] [Related]
9. Analysis of direct oil contrast lymphography of upper limb lymphatics traversing the axilla -- a lesson from the past -- contribution to the concept of axillary reverse mapping. Pavlista D; Eliska O Eur J Surg Oncol; 2012 May; 38(5):390-4. PubMed ID: 22336143 [TBL] [Abstract][Full Text] [Related]
10. Lymphedema following breast cancer treatment, including sentinel lymph node biopsy. Armer J; Fu MR; Wainstock JM; Zagar E; Jacobs LK Lymphology; 2004 Jun; 37(2):73-91. PubMed ID: 15328760 [TBL] [Abstract][Full Text] [Related]
11. Axillary reverse lymphatic mapping in breast cancer surgery: a comprehensive review. Seyednejad N; Kuusk U; Wiseman SM Expert Rev Anticancer Ther; 2014 Jul; 14(7):771-81. PubMed ID: 24621187 [TBL] [Abstract][Full Text] [Related]
12. Axillary reverse mapping (ARM): where to go. Shao X; Sun B; Shen Y Breast Cancer; 2019 Jan; 26(1):1-10. PubMed ID: 29961238 [TBL] [Abstract][Full Text] [Related]
13. Axillary reverse mapping: Is it feasible in locally advanced breast cancer patients? Khandelwal R; Poovamma CU; Shilpy C; Prema M; Anthony P Breast Dis; 2014 Jan; 34(4):151-5. PubMed ID: 24934169 [TBL] [Abstract][Full Text] [Related]
14. Extensive nodal disease may impair axillary reverse mapping in patients with breast cancer. Ponzone R; Cont NT; Maggiorotto F; Cassina E; Mininanni P; Biglia N; Sismondi P J Clin Oncol; 2009 Nov; 27(33):5547-51. PubMed ID: 19826123 [TBL] [Abstract][Full Text] [Related]
15. A patient- and assessor-blinded randomized controlled trial of axillary reverse mapping (ARM) in patients with early breast cancer. Beek MA; Gobardhan PD; Klompenhouwer EG; Menke-Pluijmers MB; Steenvoorde P; Merkus JW; Rutten HJ; Voogd AC; Luiten EJ Eur J Surg Oncol; 2020 Jan; 46(1):59-64. PubMed ID: 31402072 [TBL] [Abstract][Full Text] [Related]
16. Upper outer boundaries of the axillary dissection. Result of the SENTIBRAS protocol: Multicentric protocol using axillary reverse mapping in breast cancer patients requiring axillary dissection. Nos C; Clough KB; Bonnier P; Lasry S; Le Bouedec G; Flipo B; Classe JM; Missana MC; Doridot V; Giard S; Charitansky H; Charles-Nelson A; Bats AS; Ngo C Eur J Surg Oncol; 2016 Dec; 42(12):1827-1833. PubMed ID: 27769634 [TBL] [Abstract][Full Text] [Related]
17. The Efficacy of Axillary Reverse Mapping for the Prevention of Lymphedema. Ruffino AE; Madera JD; Dearborn MM; Frank K; Oxenberg JC Am Surg; 2024 Feb; 90(2):199-206. PubMed ID: 37619219 [TBL] [Abstract][Full Text] [Related]
18. A risk score model predictive of the presence of additional disease in the axilla in early-breast cancer patients with one or two metastatic sentinel lymph nodes. Canavese G; Bruzzi P; Catturich A; Vecchio C; Tomei D; Del Mastro L; Carli F; Guenzi M; Lacopo F; Dozin B Eur J Surg Oncol; 2014 Jul; 40(7):835-42. PubMed ID: 24684810 [TBL] [Abstract][Full Text] [Related]
19. Conservative axillary surgery in breast cancer patients undergoing mastectomy: long-term results. Cowher MS; Grobmyer SR; Lyons J; O'Rourke C; Baynes D; Crowe JP J Am Coll Surg; 2014 Apr; 218(4):819-24. PubMed ID: 24655877 [TBL] [Abstract][Full Text] [Related]
20. Axillary reverse mapping for breast cancer. Noguchi M Breast Cancer Res Treat; 2010 Feb; 119(3):529-35. PubMed ID: 19842033 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]